Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2^−/− Mice and Human Intrahepatic Cholangiocyte Organoid Models

Researchers explored the therapeutic potential of human placental MSCs in primary sclerosing cholangitis through the Takeda G protein-coupled receptor 5 (TGR5) receptor pathway.